Short Interest in Applied DNA Sciences, Inc. (NASDAQ:APDN) Drops By 46.5%

Applied DNA Sciences, Inc. (NASDAQ:APDN) was the recipient of a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 3,000,000 shares, a drop of 46.5% from the February 13th total of 5,610,000 shares. Based on an average daily trading volume, of 4,570,000 shares, the short-interest ratio is presently 0.7 days. Approximately 5.4% of the company’s shares are short sold.

Applied DNA Sciences Stock Performance

Applied DNA Sciences stock opened at $2.26 on Friday. The stock’s 50 day moving average price is $0.21 and its 200 day moving average price is $0.43. The firm has a market capitalization of $124.73 million, a PE ratio of -0.40 and a beta of 0.43. Applied DNA Sciences has a one year low of $1.95 and a one year high of $522.00.

Applied DNA Sciences (NASDAQ:APDN) last announced its quarterly earnings data on Thursday, February 13th. The technology company reported ($0.56) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.24). Applied DNA Sciences had a negative net margin of 228.12% and a negative return on equity of 101.57%. On average, analysts forecast that Applied DNA Sciences will post -0.87 earnings per share for the current fiscal year.

Institutional Trading of Applied DNA Sciences

Several large investors have recently added to or reduced their stakes in APDN. Jane Street Group LLC acquired a new stake in shares of Applied DNA Sciences during the 3rd quarter valued at $48,000. Geode Capital Management LLC boosted its position in Applied DNA Sciences by 291.1% during the fourth quarter. Geode Capital Management LLC now owns 417,485 shares of the technology company’s stock valued at $85,000 after purchasing an additional 310,749 shares during the last quarter. Millennium Management LLC acquired a new position in Applied DNA Sciences in the fourth quarter worth approximately $28,000. Finally, Connective Capital Management LLC bought a new position in Applied DNA Sciences during the fourth quarter valued at about $36,000. 22.22% of the stock is currently owned by institutional investors and hedge funds.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.